Canadian Consensus Recommendations on the Management of <i>MET</i>-Altered NSCLC

Canadian Consensus Recommendations on the Management of <i>MET</i>-Altered NSCLC

In Canada, the therapeutic management of patients with advanced non-small cell lung cancer (NSCLC) with rare actionable mutations differs between provinces, territories, and individual centres based on access to molecular testing and funded treatments. These variations, together with the emergence o...

Popoln opis

Bibliografske podrobnosti
Main Authors: Parneet K. Cheema, Shantanu O. Banerji, Normand Blais, Quincy S.-C. Chu, Patrice Desmeules, Rosalyn A. Juergens, Natasha B. Leighl, Brandon S. Sheffield, Paul F. Wheatley-Price, Barbara L. Melosky
Format: Article
Jezik:English
Izdano: MDPI AG 2021-11-01
Serija:Current Oncology
Teme:
non-small cell lung cancer
<i>MET</i> exon 14 skipping mutations
<i>MET</i> amplification
<i>MET</i> inhibitors
EGFR resistance
Online dostop:https://www.mdpi.com/1718-7729/28/6/386

Internet

https://www.mdpi.com/1718-7729/28/6/386

Podobne knjige/članki